Entresto यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

entresto

novartis europharm limited - sacubitril, valsartan - zástava srdca - angiotensin ii protivníci, ďalšie kombinácie, agentov konajúcich na renin-angiotensin system - paediatric heart failureentresto is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction. adult heart failureentresto is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction.

Neparvis यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

neparvis

novartis europharm limited - sacubitril, valsartan - zástava srdca - Činidlá pôsobiace na systém renín-angiotenzín - paediatric heart failureneparvis is indicated in children and adolescents aged one year or older for treatment of symptomatic chronic heart failure with left ventricular systolic dysfunction (see section 5. adult heart failureneparvis is indicated in adult patients for treatment of symptomatic chronic heart failure with reduced ejection fraction (see section 5.

Aqumeldi यूरोपीय संघ - स्लोवाक - EMA (European Medicines Agency)

aqumeldi

proveca pharma limited - enalapril (maleate) - zástava srdca - Činidlá pôsobiace na systém renín-angiotenzín - treatment of heart failure.